Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial

William J Anderson, Philip Short, Peter A Williamson, Brian J Lipworth

    Research output: Contribution to journalArticlepeer-review

    39 Citations (Scopus)

    Abstract

    International guidelines advocate a standard approach to asthma management for all, despite its heterogeneity. "Personalized" treatment of inflammatory asthma phenotypes confers superior benefits. We wished to evaluate dose response to inhaled corticosteroids (ICSs) in patients with asthma with an elevated fractional exhaled nitric oxide (Feno) phenotype using domiciliary measurements.
    Original languageEnglish
    Pages (from-to)1553-61
    Number of pages9
    JournalChest
    Volume142
    Issue number6
    DOIs
    Publication statusPublished - Dec 2012

    Fingerprint Dive into the research topics of 'Inhaled corticosteroid dose response using domiciliary exhaled nitric oxide in persistent asthma: the FENOtype trial'. Together they form a unique fingerprint.

    Cite this